Health
Beyond 'Ozempic feet': The surprising body changes doctors are seeing with rapid GLP-1 weight loss
"Ozempic feet" is the latest nickname for a growing list of cosmetic and physical changes linked to rapid weight loss.
Health
News about healthcare, drugs and all the supposed "wellness" flimflam.
Health
New York sues PFAS 'forever chemical' manufacturers
The companies contributed to decades of toxic PFAS pollution through their use in consumer products, the suit alleges.
Health
Implant could eliminate weekly GLP-1 weight-loss shots - but it's still years away
The goal is to solve one of the biggest problems with GLP-1 drugs: patients quitting treatment because of cost, side effects or injection fatigue.
Health
Litigators jockey for advantage as MDL 3094, 3163 GLP-1 court cases maneuver through pretrial
Attorneys on both sides of MDL 3094 and MDL 3163 are maneuvering and jockeying for position as multi-district litigation against the makers of GLP-1 drugs including Ozempic, Wegovy, Rybelsus, Trulicity and Mounjaro edges closer to actual testimony. The cases break down into two categories: those claiming gastrointestinal injury
Health
GLP-1 Lawsuit & News Tracker: Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity
The GLP-1 family of drugs might be the biggest thing since AI. There have been unexpected benefits and about as many unexpected problems.
Health
$50 Medicare GLP-1 'bridge' presents a difficult entry process
The GLP-1 "bridge" is confusing to get into and its benefits are questionable given its temporary nature.
Health
Extreme heat can be hard on your eyes, too
Heat waves can worsen dry eye by speeding tear evaporation and increasing dehydration.
Health
DOJ drops criminal baby-formula probe; Abbott avoids charges
Senior feds terminate criminal investigation of Abbott Labs baby-formula contamination.
Health
Benadryl is still everywhere. Brain-health warnings haven’t slowed its use
The popular over-the-counter medicine is easy to buy, but geriatric experts have warned for years that diphenhydramine can be risky for older adults
Seniors
Medicare opens first weight-loss coverage at $50 a month
A new pilot Medicare program, "set to continue through 2027, will allow older adults to access GLP-1 medications for $50 per month" — the first time the program will cover them specifically for weight loss,
Health
FDA cracks down on telehealth weight-loss drug marketing
Regulators say some firms falsely implied their products were equivalent to FDA-approved medications such as Wegovy, Ozempic, Zepbound, and Mounjaro. The U.S. Food and Drug Administration has intensified its campaign against the booming online weight-loss drug industry, issuing warning letters to 25 telehealth companies that allegedly made
Seniors
If you want out of Medicare Advantage, a 12-month calendar is your best friend
Seniors are finding that insurers are denying prior authorization for long-term care and rehabilitation. Are they trapped? Some are, but not everyone.